Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

16.28
+0.26501.66%
Volume:2.78M
Turnover:44.86M
Market Cap:18.67B
PE:-14.24
High:16.28
Open:16.06
Low:16.03
Close:16.01
Loading ...
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 25, 2021

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

8-K - Current report